Advances in chronic kidney disease · 2014
Hereditary kidney cancer syndromes.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Haas Naomi B, Nathanson Katherine L
Аннотация
Inherited susceptibility to kidney cancer is a fascinating and complex topic. Our knowledge about types of genetic syndromes associated with an increased risk of disease is continually expanding. Currently, there are 10 syndromes associated with an increased risk of all types of kidney cancer, which are reviewed herein. Clear cell kidney cancer is associated with von Hippel Lindau disease, chromosome 3 translocations, PTEN hamartomatous syndrome, and mutations in the BAP1 gene as well as several of the genes encoding the proteins comprising the succinate dehydrogenase complex (SDHB/C/D). Type 1 papillary kidney cancers arise in conjunction with germline mutations in MET and type 2 as part of hereditary leiomyomatosis and kidney cell cancer (fumarate hydratase [FH] mutations). Chromophone and oncocytic kidney cancers are predominantly associated with Birt-Hogg-Dubé syndrome. Patients with Tuberous Sclerosis Complex (TSC) commonly have angiomyolipomas and rarely their malignant counterpart epithelioid angiomyolipomas. The targeted therapeutic options for the kidney cancer associated with these diseases are just starting to expand and are an area of active clinical research.
Предметные рубрики MeSH
Birt-Hogg-Dube SyndromeCarcinoma, Renal CellChromosomes, Human, Pair 3Genetic Predisposition to DiseaseHamartoma Syndrome, MultipleHumansKidney NeoplasmsLeiomyomatosisNeoplastic Syndromes, HereditaryProto-Oncogene Proteins c-metSkin NeoplasmsSuccinate DehydrogenaseTranslocation, GeneticTuberous SclerosisTumor Suppressor ProteinsUbiquitin ThiolesteraseUterine Neoplasmsvon Hippel-Lindau Disease